Coeptis Therapeutics (NASDAQ:COEP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Coeptis Therapeutics (COEP) operate in?

Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Coeptis Therapeutics Stock (NASDAQ: COEP) stock price, news, charts, stock research, profile.

Open	$10.86
Close	$10.52
Volume / Avg.	89.42K / 392.37K
Day Range	$9.82 - $11.14
52 Wk Range	2.31 - 13.70
Market Cap	$34.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	0.7%
Days to Cover	1

Recent News

Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues

Unlike Party City and Big Lots, The Container Store is staying in business. Plus, an oncology company searches for a deal.

Anthony Noto

Why Is Coeptis Therapeutics Stock Falling On Friday?

Coeptis Therapeutics stock drops 22.5% after announcing a 1-for-20 reverse stock split to meet Nasdaq's listing requirements.

Nabaparna Bhattacharya

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$10.86
Close	$10.52
Volume / Avg.	89.42K / 392.37K
Day Range	$9.82 - $11.14
52 Wk Range	2.31 - 13.70
Market Cap	$34.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	49
Short Interest	0.7%
Days to Cover	1

About Coeptis Therapeutics Holdings Inc

Sector

Health Care

Industry

Biotechnology

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms f...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Coeptis Therapeutics (COEP) stock?

You can purchase shares of Coeptis Therapeutics (NASDAQ:COEP) through any online brokerage.

View our list of the best stock brokerages

Who are Coeptis Therapeutics (COEP) competitors?

Other companies in Coeptis Therapeutics’s space includes: Intensity Therapeutics (NASDAQ:INTS), CollPlant Biotechnologies (NASDAQ:CLGN), OKYO Pharma (NASDAQ:OKYO), iBio (AMEX:IBIO) and RenovoRx (NASDAQ:RNXT).

What is the forecast, or price target, for Coeptis Therapeutics (COEP) stock?

Coeptis Therapeutics has a consensus price target of $5.67.

What is the current price for Coeptis Therapeutics (COEP)?

The stock price for Coeptis Therapeutics (NASDAQ: COEP) is $10.5 last updated February 21, 2025 at 5:51 PM EST.

Does Coeptis Therapeutics (COEP) pay a dividend?

There are no upcoming dividends for Coeptis Therapeutics.

When is Coeptis Therapeutics (NASDAQ:COEP) reporting earnings?

Coeptis Therapeutics’s Q1 earnings are confirmed for Friday, May 9, 2025.

Is Coeptis Therapeutics (COEP) going to split?

There is no upcoming split for Coeptis Therapeutics.

What sector and industry does Coeptis Therapeutics (COEP) operate in?

Coeptis Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Coeptis Therapeutics

Coeptis Therapeutics (COEP) Forecast